abstract |
The present invention provides a compound having a structure of Formula 1 or 2 or a pharmaceutically acceptable salt thereof. Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are as defined in the specification. The present invention is useful for the treatment of inflammatory components of the disease, in particular for the treatment of atherosclerosis, myocardial infarction, congestive heart failure, inflammatory visceral disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. Do.n n n [Formula 1]n n n n n n n n [Formula 2] |